Modeled dalbavancin transmembrane clearance during intermittent and continuous renal replacement therapies Article (Faculty180)

cited authors

  • Vilay, A M; Shah, Kris H; Churchwell, Mariann D; Patel, Jignes H; DePestel, Daryl D D; Mueller, Bruce A

description

  • Knowledge of dalbavancin renal replacement therapy (RRT) disposition is vital to ensure appropriate dosing. In vitro models of continuous RRT and intermittent hemodialysis (IHD) were used to determine dalbavancin transmembrane clearance (CLtm).

publication date

  • 2010

published in

start page

  • 37

end page

  • 43

volume

  • 30